These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11416984)

  • 21. Cytokines, immuno-inflammatory response and atherosclerosis.
    Tedgui A; Bernard C
    Eur Cytokine Netw; 1994; 5(3):263-70. PubMed ID: 7948763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
    Camejo G
    Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.
    Lundahl B; Skoglund-Andersson C; Caslake M; Bedford D; Stewart P; Hamsten A; Packard CJ; Karpe F
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E739-45. PubMed ID: 16291571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis.
    Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
    Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
    Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.
    Nakashima Y; Wight TN; Sueishi K
    Cardiovasc Res; 2008 Jul; 79(1):14-23. PubMed ID: 18430750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino terminal 38.9% of apolipoprotein B-100 is sufficient to support cholesterol-rich lipoprotein production and atherosclerosis.
    Chen Z; Fitzgerald RL; Saffitz JE; Semenkovich CF; Schonfeld G
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):668-74. PubMed ID: 12615667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein-matrix interactions in macrovascular disease in diabetes.
    Tannock LR; Chait A
    Front Biosci; 2004 May; 9():1728-42. PubMed ID: 14977582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-localization of aortic apolipoprotein B and chondroitin sulfate in an injury model of atherosclerosis.
    Galis ZS; Alavi MZ; Moore S
    Am J Pathol; 1993 May; 142(5):1432-8. PubMed ID: 8494047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low density lipoprotein stimulation of human macrophage proteoglycan secretion.
    Lindholm MW; Nilsson J; Moses J
    Biochem Biophys Res Commun; 2005 Mar; 328(2):455-60. PubMed ID: 15694369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
    Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New findings on the pathogenesis of atherosclerosis].
    Fialová L
    Cesk Fysiol; 1995 Jun; 44(2):92-101. PubMed ID: 8665598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
    Fredrikson GN; Söderberg I; Lindholm M; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):879-84. PubMed ID: 12649092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of inflammation in atherogenesis].
    Rodríguez G; Mago N; Rosa F
    Invest Clin; 2009 Mar; 50(1):109-29. PubMed ID: 19418732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inflammation and atherosclerosis].
    Capron L
    J Mal Vasc; 1989; 14 Suppl A():3-12. PubMed ID: 2654313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.